Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - AKCEA THERAPEUTICS, INC. | a2232137zex-23_1.htm |
| EX-21.1 - EX-21.1 - AKCEA THERAPEUTICS, INC. | a2232137zex-21_1.htm |
| EX-10.3 - EX-10.3 - AKCEA THERAPEUTICS, INC. | a2232137zex-10_3.htm |
| EX-10.2 - EX-10.2 - AKCEA THERAPEUTICS, INC. | a2232137zex-10_2.htm |
| EX-5.1 - EX-5.1 - AKCEA THERAPEUTICS, INC. | a2232137zex-5_1.htm |
| EX-4.1 - EX-4.1 - AKCEA THERAPEUTICS, INC. | a2232137zex-4_1.htm |
| EX-3.2 - EX-3.2 - AKCEA THERAPEUTICS, INC. | a2232137zex-3_2.htm |
| EX-3.1 - EX-3.1 - AKCEA THERAPEUTICS, INC. | a2232137zex-3_1.htm |
| S-1/A - S-1/A - AKCEA THERAPEUTICS, INC. | a2232137zs-1a.htm |
Exhibit 10.11
|
|
Akcea Therapeutics, Inc. 55 Cambridge Parkway, Suite 100 Cambridge, MA 02142 |
MEMORANDUM
Date: Effective upon closing of Akcea’s IPO
To: Akcea Board of Directors
From: Paula Soteropoulos, President & CEO
Subject: Board of Director Compensation
Akcea values the contributions made by its Board of directors. In recognition of these valuable contributions, Akcea will provide each non-employee Director(1) with the compensation described in this memo.
Cash Compensation
Each non-employee Director will receive cash compensation based on his/her role on the Board and Board committees:
|
Role |
|
Cash Compensation |
| |
|
Board Member (Base retainer) |
|
$ |
35,000 |
|
|
Chairman of the Board (Additional) |
|
$ |
25,000 |
|
|
Committee Chairs (Additional) |
|
|
| |
|
- Audit |
|
$ |
15,000 |
|
|
- Compensation |
|
$ |
10,000 |
|
|
- Nominating & Gov. |
|
$ |
7,500 |
|
|
Committee Member (Additional) |
|
|
| |
|
- Audit |
|
$ |
7,500 |
|
|
- Compensation |
|
$ |
5,000 |
|
|
- Nominating & Gov. |
|
$ |
3,750 |
|
Equity Compensation
Each non-employee Director will receive an initial stock option award upon joining the Board, and will receive an annual stock option award for each year of continued service, as follows:
|
Stock Option Award |
|
No. of Shares |
|
|
Initial Stock Option Equity Grant |
|
52,837 |
|
|
Annual Stock Option Equity Grant |
|
26,418 |
|
The exercise price of each option will be the fair market value of Akcea’s common stock on the date of grant. The options will vest over a four-year period in equal annual installments and be subject to the terms of Akcea’s 2015 Equity Incentive Plan. The vesting of the options will accelerate in the case of a change of control of Akcea, as further described your option agreement and the 2015 Equity Incentive Plan.
Akcea reserves the right to amend this compensation policy at any time.
(1) Employees or Directors of Ionis who serve on the Akcea Board are not eligible for compensation as Akcea Board members.